We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VERA market cap is 2.62B. The company's latest EPS is USD -1.5159 and P/E is -27.32.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -21.76M | -27.03M | -31.11M | -37.34M | -49.8M |
| Net Income | -20.1M | -25.66M | -28.38M | -33.71M | -46.63M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.96M | -52.24M | -34.4M | -90.9M | -102.01M |
| Net Income | -11.85M | -53.41M | -32.61M | -89.06M | -95.99M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 175.62M | 175.55M | 419.36M | 397.29M | 368.56M |
| Total Liabilities | 51.91M | 73.86M | 65.81M | 69.42M | 79.5M |
| Total Equity | 123.71M | 101.69M | 353.54M | 327.87M | 289.06M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.38M | 54.55M | 83.75M | 131.44M | 175.55M |
| Total Liabilities | 1.83M | 4.33M | 14.16M | 54.53M | 73.86M |
| Total Equity | -36.55M | -89.35M | 69.59M | 76.91M | 101.69M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -67.04M | -92.18M | -33.83M | -58.61M | -95.5M |
| Investing | -57.99M | -39.43M | -219.29M | -241.96M | -203.65M |
| Financing | 108.71M | 133.54M | 276.54M | 279.98M | 280.72M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.29M | -34.81M | -23.71M | -67.6M | -92.18M |
| Investing | -125k | -42k | -4.2M | -70.55M | -39.43M |
| Financing | -137k | 85.29M | 53.88M | 101.93M | 133.54M |
| Market Cap | 2.62B |
| Price to Earnings Ratio | -27.32 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 57.4 |
| Price to Book Ratio | 25.79 |
| Dividend Yield | - |
| Shares Outstanding | 63.32M |
| Average Volume (1 week) | 760.58k |
| Average Volume (1 Month) | 504.93k |
| 52 Week Change | 156.89% |
| 52 Week High | 51.61 |
| 52 Week Low | 14.20 |
| Spread (Intraday) | 26.79 (42.67%) |
| Company Name | Vera Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://veratx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
